je.st
news
Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research
2015-12-21 05:46:43| Biotech - Topix.net
The firm currently has a $43.00 target price on the stock. Zacks Investment Research 's price target would indicate a potential upside of 11.46% from the company's previous close.
Tags: research
investment
upgraded
zacks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||